Home / News / India News / Article /
DCGI grants regular market approval for Covishield, Covaxin with conditions
Updated On: 27 January, 2022 05:15 PM IST | New Delhi | IANS
`The conditions include supply for programmatic settings including registration on the CoWin platform and to continue to submit safety data on a six-monthly basis,` said Union Health minister Mansukh Mandaviya in a tweet
Listen to this article :
This picture has been used for representational purpose
The Drugs Controller General of India (DCGI) granted regular market approval for Covid-19 vaccines - Covishield and Covaxin - for use in adult population with certain conditions.
Bharat Biotech`s Covaxin and Serum Institute of India`s Covishield have been given regular market approval with certain conditions of registration on the CoWin platform and the submission of safety data on a six-monthly basis.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT